Advertisement

Topics

UTILITY therapeutics Ltd Company Profile

14:23 EDT 20th September 2018 | BioPortfolio

UTILITY is focused on developing and commercialising antibiotics in the US, to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections. The World Health Organisation has stated that antibiotic resistance is one of the biggest threats to global health, food security, and development today.


News Articles [862 Associated News Articles listed on BioPortfolio]

UTILITY therapeutics signs license agreement with LEO Pharma A/S for US rights to mecillinam ...

For more information, please contact:UTILITY therapeutics LtdMark Beards, CEO, +44 203 930 9665info@utilitytherapeutics.comorConsilium Strategic CommunicationsMary-Jane Elliott, Ivar Mil...

UTILITY Receives Qualified Infectious Disease Product Designation for Uncomplicated Urinary ...

UTILITY therapeuticsMark Beards, +44 203 930 9665CEOinfo@utilitytherapeutics.comorConsilium Strategic CommunicationsMary-Jane Elliott, David Daley, Ivar Milligan, Chris Welsh, +44 20 370...

Newly-formed company in-licenses LEO Pharma antibiotics

Denmark's LEO Pharma has done a deal to give UTILITY therapeutics an exclusive license for the antibiotics…

Precision Medicine Success Hinges On Diagnostics' Clinical Utility

Establishing clinical utility is crucial to ensuring a diagnostic’s reimbursement, which in turn facilitates uptake, not only of the diagnostic but also the precision therapeutic.

KEEN Utility® Kicks off Epic Road Trip to Meet North America's Hardest Workers

The seven-month journey kicks off on April 5, 2018, leaving from the brand's home office where KEEN Utility brand ambassadors have been packing the Read more...

Bulbs.com, the online authority in LED lighting, announces another Utility Rebate Partnership

BOSTON, Sept. 18, 2018 /PRNewswire/ -- Bulbs.com, the online authority in LED Lighting, continues to expand its rebate distribution partnerships with utility companies across the Read more...

UTILITY Receives Qualified Infectious Disease Product Designation for Uncomplicated Urinary Tract Infections from US FDA

UTILITY therapeutics Ltd (“UTILITY” or “the Company”), a pharmaceutical company focused on developing and commercialising antibiotics in the US, today announced that the U...

UTILITY Receives Qualified Infectious Disease Product Designation from the U.S. FDA

UTILITY therapeutics Ltd (“UTILITY” or “the Company”), a pharmaceutical company focused on developing and commercialising antibiotics in the US, today announced that the U...

PubMed Articles [809 Associated PubMed Articles listed on BioPortfolio]

Cardiac MRI for the evaluation of oncologic cardiotoxicity.

Cancer therapeutics-related cardiac dysfunction (CTRCD) is a well-established adverse effect resulting from a number of cancer therapeutics. Newer immunotherapy has been associated with cardiomyopathy...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

The Perceptions of Dentists Working in Saudi Arabia of the Utility of Different Restoration Options for a Shortened Dental Arch in Patients of Different Ages.

This study aimed to assess dentists' views of the utility of an unrestored shortened dental arch (SDA) compared to the utility of various prosthetic treatment options.

Cost-utility analysis of cervical deformity surgeries using one-year outcome.

Cost-utility analysis, a special case of cost-effectiveness analysis, estimates the ratio between the cost of an intervention to the benefit it produces in number of quality-adjusted life years. Cervi...

Clinical Trials [920 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS

This is a prospective evaluation of the clinical utility of the new cholangioscopy platform SpyGlass DS. The aims of this study are to prospectively document the clinical utility and techn...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1354 Associated Companies listed on BioPortfolio]

UTILITY therapeutics Limited

UTILITY therapeutics is focused on developing and commercialising antibiotics in the US, to address the significant threat faced by healthcare systems and patients from multi-drug...

UTILITY therapeutics Ltd

UTILITY is focused on developing and commercialising antibiotics in the US, to address the significant threat faced by healthcare systems and patients from multi-drug resistant ba...

Focal Therapeutics

Focal Therapeutics is a medical device company based in Silicon Valley. The company’s first product is the BioZorb™ tissue marker, a bioabsorbable device that provides r...

ZymoGentics Incorporated

We have had a continuous 20-year focus on the discovery and development of therapeutic proteins. In our early years, we utilized a "biology-first" approach where we evaluated the biology of a disease ...

EKR Therapeutics, Inc.

EKR Therapeutics is a specialty pharmaceutical company focused on acquiring, developing and maximizing the potential utility of critical-care hospital products offering broader th...

More Information about "UTILITY therapeutics Ltd" on BioPortfolio

We have published hundreds of UTILITY therapeutics Ltd news stories on BioPortfolio along with dozens of UTILITY therapeutics Ltd Clinical Trials and PubMed Articles about UTILITY therapeutics Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of UTILITY therapeutics Ltd Companies in our database. You can also find out about relevant UTILITY therapeutics Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...


Corporate Database Quicklinks



Searches Linking to this Company Record